Announced
Completed
Financials
Sources
Tags
Cross Border
Single Bidder
Private
Friendly
Acquisition
biotechnology
Majority
Completed
Netherlands
Biotechnology
Synopsis
Solvias, a company in contract research, development and manufacturing for the pharmaceutical, biotech, material science and cosmetic industries, completed the acquisition of Cergentis, a trusted genomics-focused biotechnology company. Financial terms were not disclosed. “We are relentlessly focused on ensuring the safety of new therapies in development. Cergentis is a cornerstone acquisition that expands our solutions supporting complex and emerging therapies. We will continue to pursue strategic acquisitions that add specialized capabilities to our offering and advance our goal of being a forerunner in our industry,” Archie Cullen, Solvias CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.